| abstract |
The invention relates to a new purine derivative, which is {9 - [(2,5-dimethylphenyl) methyl] -2- (morpholin-4-yl) purin-8-yl} methanol. The compound has the properties of a modulator of TNFα activity and can be used to prepare a drug for treating and / or preventing rheumatoid arthritis or Crohn's disease. 4 bp f-ly, 1 ex. |